Table 2 Clinical characteristics of patients receiving warfarin compared between UMC and PLAC at TASH
Characteristics | Total ( N = 525) n (%) | UMC Group ( N = 350) n (%) | PLAC Group ( N = 175) n (%) | P-value |
|---|---|---|---|---|
Presence of heart problems or comorbidities | ||||
 Yes | 401(76.4) | 288(82.3) | 113(64.6) |  < 0.001 |
Underlying heart problems, comorbidities, or medication use | ||||
 Heart failure | 209(39.8) | 158(45.4) | 51(29.1) |  < 0.001 |
 Valvular heart disease | 202(38.5) | 145(41.4) | 57(32.6) | 0.06 |
 Hypertension | 109(20.8) | 84(24.0) | 25(14.3) | 0.01 |
 Stroke and thromboembolism history | 88(16.8) | 66(18.9) | 22(12.6) | 0.08 |
 Amiodarone use | 6 (1.1) | 6 (1.7) | 0 (0) | 0.19 |
 Aspirin, clopidogrel, NSAIDs use | 31 (5.9) | 26 (7.4) | 5 (2.9) | 0.04 |
 Pulmonary Hypertension | 63(12.0) | 43(12.3) | 20(11.4) | 0.78 |
 Vascular heart disease historyb | 43(8.2) | 39(11.1) | 4(2.3) |  < 0.001 |
 Diabetes Mellitus | 35(6.7) | 28(8.0) | 7(4.0) | 0.08 |
 Neurologic disordersc | 22(4.2) | 19(5.4) | 3(1.7) | 0.06 |
 CAD/IHD without thrombus | 20(3.8) | 18(5.1) | 2(1.1) | 0.02 |
 Seizure disorders | 20(3.8) | 17(4.9) | 3(1.7) | 0.09 |
 Cardiomyopathy | 23(4.4) | 17(4.9) | 6(3.4) | 0.51 |
 HIV/AIDS | 14(2.7) | 12(3.4) | 2(1.1) | 0.16 |
 Cancer | 13(2.5) | 12(3.4) | 1(0.6) | 0.07 |
 Hypertensive heart disease | 20(3.8) | 11(3.1) | 9(5.1) | 0.33 |
 Hyperthyroidism | 14(2.7) | 10(2.9) | 4(2.3) | 0.78 |
 Chronic Pulmonary diseasesd | 14(2.7) | 10(2.9) | 4(2.3) | 0.78 |
 Dyslipidemia | 11(2.1) | 10(2.9) | 1(0.6) | 0.11 |
 Rheumatologic diseases | 13(2.5) | 9(2.6) | 4(2.3) | 0.55 |
 Gastric illness/peptic ulcer diseases | 10(1.9) | 9(2.6) | 1(0.6) | 0.18 |
 Portal hypertension | 7(1.3) | 7(2.0) | 0(0.0) | 0.10 |
 Renal Diseases | 12(2.3) | 8(2.3) | 4(2.3) | 0.63 |
 Liver diseases | 11(2.1) | 8(2.3) | 3(1.7) | 0.76 |
 Polycythemia vera | 8(1.5) | 8(2.3) | 0(0) |  < 0.001 |
 Iron deficiency anemia | 7(1.3) | 6(1.7) | 1(0.6) | 0.43 |
 Hypothyroidism | 6(1.1) | 4(1.1) | 2(1.1) | 0.68 |
 Psychiatric disorders | 5(0.9) | 3(0.9) | 2(1.1) | 0.54 |
 Otherse | 27(5.1) | 18(5.1) | 9(5.1) | 0.59 |